Tag: Cancer: Prostate
Snus Use Tied to Higher Risk of Prostate Cancer Mortality
Safety of the smokeless tobacco product called into question
ASTRO: No Survival Benefit for Adding EBT to Brachytherapy
Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer
Drop in Use of Digital Rectal Examination, PSA Testing
Decreases in use of screening following USPSTF recommendations against routine PSA screening
No Link Found Between Vasectomy, Prostate Cancer Risk
Large study challenges previous research linking the procedure to slightly higher chance of disease
Testosterone Seems Safe for Hypogonadal Prostate CA Patients
Testosterone therapy seems oncologically safe after treatment or for those on active surveillance
Outlook Good for Localized Prostate CA, Despite Tx Chosen
Survival rates high for active surveillance, radiation, or prostatectomy
PSA Failure Predicts Death in Men With No, Minimal Comorbidity
Findings among men with localized intermediate- and high-risk prostate cancer
Decision Regret Uncommon After Radical Prostatectomy, IMRT
Overall decision regret for 16.9 percent of patients; more regret for RP than radiotherapy component
USPSTF Ruling Followed by Fall in Early Prostate Cancer Diagnoses
Rates per 100,000 men have dropped from 356.5 to 335.4 in men aged 50 to 74
Sociodemographic Factors Affect Prostate CA Treatment Initiation
Non-Hispanic black men more likely to begin active treatment, independent of clinical measures
